|
|
| home about us advertise with us downloads links privacy contact us site map copyright policy |
| ||
NIH Bio SpiegelEndoscopic screening for esophageal varices in cirrhosis: is it ever cost-effective? The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. 8. Targownik LE, Spiegel BM, Dulai GS, Karsan HA, Gralnek IM. The cost-effectiveness of hepatic pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. American Journal of Gastroenterology 2004;99:1306-15 9. Spiegel BMR, Targownik LE, DeRosa V, Dulai GS, Gralnek IM, Chiou CF. This project will aim to design and validate a concise, clinically useful extraintestinal symptom questionnaire in irritable bowel syndrome. This project will measure the reliability of an extraintestinal symptom questionnaire in irritable bowel syndrome. This project will compare a multifactorial intervention aimed at improving the physician-patient relationship versus usual care in the management of irritable bowel syndrome.Introduction: Many patients with irritable bowel syndrome (IBS) feel that they have some form of dietary allergy or intolerance. IgE mediated food reactions (classic allergies) are probably rare in IBS but little attention has been paid to the potential role of IgG responses. This study aimed to assess the efficacy of an exclusion diet based on testing for the presence of IgG food antibodies in patients with IBS. Methods: A double blind randomised controlled trial was undertaken in which 150 unselected out-patients with IBS (all subtypes) were randomised to receive either a diet excluding, for 3 months, all foods to which they had IgG antibodies (titre > 3:1) or a sham diet excluding the same number of foods but not those to which they were sensitive. Symptom severity, non-colonic symptoms, anxiety/depression and quality of life were recorded at 0 and 3 months, and the primary outcome measure was a change in symptom severity score. Global outcome was also recorded on a seven Irritable bowel syndrome (IBS) is a painful and frequently frustrating disorder of the intestines that's often difficult to treat. Or, the pain, discomfort, and bowel dysfunction may be disabling, limiting social interactions, employment, or travel.1,2 While some individuals with IBS have diarrhea (frequent, loose stools with an urgent need to move the bowels), others have constipation (hard, infrequent stools that are difficult to pass). Individuals with IBS also may have painful abdominal cramps and feel an urgent need to move the bowels, but are unable to do so.1,2 Q. What causes IBS? The stool passes to the left side of the colon, where it is stored until a bowel movement occurs.3 Because researchers haven't been able to find actual damage in the colon, it once was suggested that individuals with IBS have emotional problems or are overly susceptible to stress. A. Normal bowel function varies from person to person. Some people move their bowels daily, while others may Cochrane Top 50 Accessed Articles.xlsTop 50 accessed articles sorted by Fulltext (Total) accesses Article Title 1 Interventions for preventing obesity in children 2 Interventions for preventing falls in elderly people 3 Glucosamine therapy for treating osteoarthritis 4 Antidepressants for neuropathic pain 5 Acupuncture for low-back pain 6 Abdominal decompression for suspected fetal compromise/pre-eclampsia 7 Anticonvulsant drugs for acute and chronic pain 8 Exercises for mechanical neck disorders 9 Exercise therapy for low-back pain 10 Metformin for type 2 diabetes mellitus 11 Gabapentin for acute and chronic pain 12 Memantine for dementia 13 Colloids versus crystalloids for fluid resuscitation in critically ill patients 14 Acetylsalicylic acid (Aspirin) for primary prevention of cardiovascular disease in type 2 diabetes 15 Decision aids for people facing health treatment or screening decisions 16 Nicotine replacement therapy for smoking cessation 24 Home-like versus conventional institutionalIrritable bowelv2The Irritable Bowel Syndrome (IBS) consists of a number of symptoms. The term `syndrome' seems quite grand but it is just the word that doctors use to describe a collection of symptoms. The most important symptoms in IBS are abdominal pain and abnormal bowel habit. Many patients with IBS get crampy abdominal discomfort or pain, which comes and goes, and is often relieved by opening the bowels. The bowel Other symptoms vary from individual to individual but include a sensation of bloating, visible abdominal swelling, a sense of incomplete emptying of the bowels and passage of mucus (slime) from the back passage. Irritable Bowel Syndrome is just about the most common disorder of the digestive system and up to one-third of the population experience symptoms from time to time. This process is usually painless and we do not realise that it is happening unless there is abnormal squeeze within the bowel or, for some reason, the intestine becomes overactive. However we do knowRitchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Pain produced by electric stimulation of the rectum in patients with irritable bowel syndrome: further evidence of visceral hy-peralgesia. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Cerebral activation in irritable bowel syndrome patients and control subjects during rectosigmoid stimulation. A com-parison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer dis-ease. Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is Fit and Feisty Word Sample FormatIrritable bowel syndrome (IBS) is a disorder that interferes with the normal functions of the large intestine (colon). It is characterized by a group of symptoms--crampy abdominal pain, bloating, constipation, and diarrhea. One in five Americans has IBS, making it one of the most common disorders diagnosed by doctors. It occurs more often in women than in men, and it usually begins around age 20. What causes one person to have IBS and not another? No one knows. Symptoms cannot be traced to a single organic cause. Research suggests that people with IBS seem to have a colon that is more sensitive and reactive than usual to a variety of things, including certain foods and stress. Call your health care provider if you have symptoms of irritable bowel syndrome or if you notice a persistent change in your bowel habits.doi:10.1016/j.ajog.2004.10.634Objective: We sought to describe irritable bowel syndrome (IBS) treatment among women with chronic pelvic pain. Chronic pelvic pain is a syndrome that is loosely defined by a long duration of pain in the pelvis. Approximately one third of women with chronic pelvic pain have irritable bowel syndrome (IBS). Compared with women with only chronic pelvic pain, those with both syndromes are more likely to have screening and diagnostic procedures performed These diagnoses were based on the physician's judgment after asking questions about bowel symptoms and evaluating questionnaire responses. The prevalence of chronic pelvic pain and irritable bowel syndrome in two university clinics. Hogston P. Irritable bowel syndrome as a cause of chronic pain in women attending a gynecology clinic. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Irritable bowel syndrome in a community: symptom subgroups, risk factors, andBowelDiseaseInflammationIrritable Bowel Syndrome (IBS) affects approximately 10% of the population with symptoms including abdominal pain, discomfort and bloating and altered bowel habit. 5-HT4 is a neurotransmitter/neuromodulator of which the main stores are found in the gastrointestinal tract. Its receptor is present in the human colon. While current 5-HT4 agonists remain a major strategy for IBS therapy to date, they have demonstrated only modest effect, despite good clinical efficacy. In addition, they have the adverse risk of inducing arrhythmia. Based on newly discovered 5-HT receptor isoforms, researchers at Monash University have developed and synthesized novel 5-HT4 agonists with improved efficacy and selectivity (5-HT4 (d)) which would overcome some of the inherent problems of their precursor therapies. Current stage of development: Currently the Monash researchers have generated 3 lead compounds that display different relative affinities for two relevant human 5-HT4flyer_KrauseJanuary 2005, 144 pp., hardcover ISBN: 1-58603-486-3 Price: US$132 / €110 / £77 Significant progress has been made in several areas of gastroenterology over the last two decades. The understanding of physiology of gastrointestinal tract covering motility, sensitivity, absorption, and molecular biology of gastrointestinal cancers, particularly colorectal cancer, has immensely improved. Recent years were dominated by increased public attention focused on functional bowel disorders. Irritable bowel syndrome is a functional bowel disorder characterized by abdominal pain and discomfort without clearly demonstrable organic cause leading to altered bowel habits. Since the prevalence of irritable bowel syndrome is high, it represents a significant societal and economic burden. Better understanding of the function of the enteric nervous system supported by the evidence that pain and discomfort experienced by the patients is due to hypersensitivity of vagal andIrritablebowelsyndromeA preliminary study was conducted on 14 patients with Irritable Bowel Syndrome for 2 months. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: Results of a controlled treatment study. . A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome. Abstract: Ten of thirteen original participants with Irritable Bowel Syndrome (IBS) participated in a one year follow-up study to determine whether the effects of Relaxation Response Meditation (RRM) on IBS symptom reduction were maintained over the long-term. A study on the therapeutic potential of some hathayogic methods in the mangement of irritable bowel syndrome. Results from a trial program conducted in spring of 2003 indicate an overall drop of 55% in symptoms of irritable bowel syndrome as reported by participants in the program. Abstract: Patients presenting with multiple medically unexplained physical symptoms, termed polysymptomatic somatizersholtenAlthough serious organic illnesses can cause these symptoms, irritable bowel syndrome is commonly responsible. A practical approach for diagnosing irritable bowel syndrome is suggested, using the Rome II criteria and the pres-ence of alarm symptoms such as weight loss, gastrointestinal bleeding, anemia, fever, or frequent nocturnal symptoms as starting points. Diagnosis and treatment of irritable bowel syndrome. Fewer than three bowel movements per week More than three bowel movements per day Hard or lumpy stools Loose (mushy) or watery stools Straining during a bowel movement Urgency (having to rush to the bathroom to have a bowel movement) Feeling of incomplete evacuation Passing mucus (white material) during a bowel Evans RW. Medical costs in community subjects with irritable bowel syndrome. Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Patient subgroups in irritable bowel syndrome that can be defined by symptom evaluation and physicalAbt Associates Inc. Health Economic Research and Quality of Life Evaluation Ser vices The HERQuLES team of Abt Associates Inc. has extensive experience conducting a variety of strategic and tactical, prospective and retrospective research and consulting ser vices in these thera-peutic areas. - Irritable bowel syndrome - Literature review of losetron (5HT3 receptor antagonist) for the treatment of irritable bowel syndrome Selected Publications receptor antagonist for the treatment of irritable bowel syndrome. SM, Pashos CL. Incidence of small-bowel obstruction and adhesiolysis after open colorectal and general surger y. Winter 2002He has done groundbreaking work on substance P, which is in the cere-brospinal fluid (CSF) and regulates how pain is transmitted. Dr. Russell found that fibromyalgia patients have elevated levels of substance P in their CSF, compared to healthy normal controls. He is an author of over 85 original publications and over 30 invited chapters in medical textbooks, and his re-search is reported in numerous lay articles. Besides coping with chronic pain and fa-tigue, many fibromyalgia patients suffer from an irritable bladder. Studies have shown that show that up to 70 percent of people with fibromyalgia may experience irritable bowel syndrome. Al-though there is no known cure for irritable bowel syndrome, a change in eating habits and stress management can help to dramati-cally reduce the onset and frequency of symptoms. Irritable bowel syndrome is caused by ex-cessive muscle spasms in the bowel, which causes a great deal of pain, discomfort, and a disturbance ofirritable-bowelc. IBS symptoms are typically unrelenting and progressive. d. IBS symptoms tend to be worst in the morning & improve throughout the day. e. IBS is associated with increased risk of inflammatory bowel disease and cancer. f. IBS is associated with a high incidence of psychopathology. g. IBS patients have quantifiable increases in bloating and colonic gas. What other conditions must you exclude? 3. What therapies have proven to be beneficial? Pain is described in varying fashion, but most commonly occurs in the LLQ. b. IBS often causes significant weight loss. e. IBS is associated with increased risk of inflammatory bowel disease and cancer.uknews-2003-06-03Cambridge-based drug company Alizyme has announced the preliminary results from a successful phase 2B clinical trial of its new product - renzapride - in patients with constipation-predominant irritable bowel syndrome (c-IBS). Medical plastics are used in a range of medical devices to treat patients in areas such as respiratory medicine, cardiology, orthopaedics, urology and ophthalmology. The prize is the Royal Society Rosalind Franklin Award, named in honour of the scientist who played a key role in that historic breakthrough. Professor Gibson, an expert in synthetic chemistry, received 30,000 pounds sterling, part of which she plans to donate towards raising the profile of women working in science, engineering and technology. It is an extremely exciting and rewarding job, and one in which a woman can have a successful career and, if they wish, combine with having a family," she said. MANY sufferers from the common complaint of irritable bowel syndrome (IBS) can,1 | 2 | 3
| 4 | 5 | 6
| 7 | 8 | 9
| 10 | 11 | 12
| 14 | 15 | | ||
